neuroRAD 2026: What the EU AI Act means for clinical neuroradiology

The EU AI Act introduces new regulatory requirements impacting clinical neuroradiology, focusing on classification of AI systems as high-risk, compliance distinctions between AI providers and deployers, and unresolved clinical liability concerns. The legislation overlaps with the EU Medical Device Regulation and calls for innovation to remain patient-centred despite increased regulation.

This Wire brief sits within Fusion42's coverage of Medtech.